Market Cap (In KRW)
1155.64 Billion
Revenue (In KRW)
1669.4 Billion
Net Income (In KRW)
212.52 Billion
Avg. Volume
59.62 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 86000.0-136500.0
- PE
- -
- EPS
- -
- Beta Value
- 0.823
- ISIN
- KR7185750007
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Young-Joo Kim
- Employee Count
- -
- Website
- https://www.ckdpharm.com
- Ipo Date
- 2013-12-06
- Details
- Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.
More Stocks
-
9502
-
2505
-
TITC
-
SSY
-
ASTRON
-
QLYSQualys, Inc.
QLYS
-
1904
-
6168Harvatek Corporation
6168